查詢結果分析
來源資料
相關文獻
- 一週四合療法對治療國人幽門曲狀桿菌感染之療效
- Campylobacter Pylori, Gastritis and Peptic Ulceration
- Gastric Emptying Half-time in Patients with Helicobacter Pylori Associated Gastritis or Gastric Ulcer Diseases
- Lansoprazole三合療法與Bismuth三合療法對國人幽門曲狀桿菌陽性消化性潰瘍療效之比較
- 胃炎的新分類與新觀念
- 舒肝養陰治療幽門桿菌胃炎
- 急、慢性胃炎的飲食療法
- 經方治「急性胃炎」之應用
- A Study of Campylobacter Pylori in Peptic Ulcer Disease
- 院內感染病毒性腸胃炎
頁籤選單縮合
題 名 | 一週四合療法對治療國人幽門曲狀桿菌感染之療效=One Week Quadruple Therapy in the Management of Helicobacter Pylori Infection in Chinese |
---|---|
作 者 | 許秉毅; 黎國洪; 林俊谷; 羅錦河; 曾暉華; 蔡奇璋; 鄭錦翔; 黃榮隆; 黃嘉生; 曾文怡; 于嘉莉; 賈愛華; | 書刊名 | 內科學誌 |
卷 期 | 9:2 1998.06[民87.06] |
頁 次 | 頁82-92 |
分類號 | 415.5 |
關鍵詞 | 幽門曲狀桿菌; 四合療法; 出血性消化性潰瘍; 胃炎; Helicobacter pylori; Quadruple therapy; Bleeding peptic ulcer; Gastritis; |
語 文 | 中文(Chinese) |
中文摘要 | 自民國86年1月至3月,我們進行一前瞻性研究以評估四合療法對國人幽門曲狀 桿菌感染之療效。在研究期間,共有25位幽門曲狀桿菌陽性之出血性消化道潰瘍患者及24 位幽門曲狀桿菌陽性之胃炎患者接受一週四合療法(colloidal bismuth subcitrate 120mg一天四 次,lansoprazole 30mg一天二次,tetracycline 500mg一天四次,metronidazole 250mg一天三 次)治療。在治療8週後,我們以胃鏡追蹤胃腸道病變及曲狀桿菌是否根除。結果:出血性 潰瘍組的患者於治療後幽門曲狀桿菌之除菌率為82%,潰瘍癒合率為73%。除菌成功與除 菌失敗的患者之潰瘍癒合率並無差異(72%比75%,P值大於0.05)。胃炎組的患者,四合療 的除菌率為67%,症狀改善率為74%。而進一步分析顯示:殺菌成功之患者的症狀改善率 高於殺菌失敗之患者(100%比33%,P值小於0.01)。整體而言,四合療法的除菌率、副作用 發生率與藥物遵從性不良率分別為75%、14%及4%。結論:本研究顯示(1)一週四合療法雖 具有患者藥物遵從性高之優點,但對幽門曲狀桿菌僅具中等程度之除菌效果。(2)去除幽門 曲狀桿菌的確可以緩解胃炎患者之上腹部不適。 i以緩解胃炎患者之上腹部不適。 |
英文摘要 | From February to June 1997, we conducted a prospective study to investigate the efficacy of 1-week quadruple therapy in treatment of Helicobacter pylori (H pylori) infection in Taiwan. During the study period, twenty0five patients with H pylori-associated bleeding peptic ulcer diseases and 24 patients with H pylori-associated gastritis received a 1-week quadruple therapy (lansoprazole 30 mg bid, colloid bismuth subcitrate 120 mg qid, tetracycline 500 mg qid, metronidazole 250 mg tid). Endoscopy was repeated at the end of the 8th week to follow up the gastrointestinal lesions and determine the status of H pylori. In the patient group with bleeding peptic ulcer, H pylori eradication was successful in 18 of 22 patients (82%), and ulcer healing was achieved in 16 of 22 cases (73%) by an intention-to-treat analysis.. There were no differences in ulcer healing rates between the patients with and without successful bacterial eradication (72% vs. 75%, p>0.005). In the patient group with gastritis, the H pylor eradication rate was 67% and the symptom scores improved in 17 of 23 patients (74%). Further analysis disclosed that the improvement rate of symptom scores in patient with successful bacterial eradication was significantly higher than the patients with eradication failure (100% vs. 33% p<.001). Overall, the H pylori eradication rate, incidences of side effect and poor drug compliance were 75%, 14% and 4% respectively. We therefore conclude that 1-week quadruple therapy is tolerated by mos of the patients, but provides only moderate efficacy for eradication of H pylori in Taiwan. In addition, dyspeptic symptoms in patients with H pylori- associated gastritis can be relieved by bacterial eradication. |
本系統中英文摘要資訊取自各篇刊載內容。